Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine

This study has been completed.
Sponsor:
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT00794235
First received: November 19, 2008
Last updated: January 7, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2010
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)